Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Satellos to Host Virtual KOL Event on SAT-3247 in Duchenne Muscular Dystrophy
-
Chicago Atlantic Real Estate Finance Schedules Fourth Quarter 2025 Earnings Release and Conference Call Date
-
ActiveCampaign Backs Autonomous Marketing with Results Guarantee
-
KalVista Pharmaceuticals Announces Inclusion of EKTERLY® (sebetralstat) as a First-Line Therapy for Adolescents 12 and Older in International Pediatric HAE Guideline
-
Two Prime Registers as Commodities Trading Advisor with the CFTC and NFA
-
Utz Brands Highlights Long Term Strategy and Differentiated Growth at 2026 CAGNY Conference
-
National Vision Holdings, Inc. Announces Fourth Quarter and Fiscal 2025 Earnings Release and Conference Call
-
Icon Group Deploys ChartCheck Adaptive Across Australia as Radformation Secures USFDA 510(k) Clearance
-
Walker & Dunlop Announces 2026 Investor Day
-
Moody's Corporation Reports Results for Fourth Quarter and Full Year 2025
-
monday.com Announces Participation in the Morgan Stanley Technology, Media & Telecom Conference
-
Macrobond Recognized in G2’s 2026 Best Software Awards for Financial Services and New Software
-
The Vita Coco Company Reports Fourth Quarter and Full Year 2025 Financial Results
-
Mister Car Wash to Be Taken Private by Leonard Green & Partners for $7.00 Per Share
-
Upwork Announces $300 Million Share Repurchase Program
-
Promega Honored as a U.S. Best-in-Class Employer by Gallagher
-
NewAmsterdam Pharma Reports Full Year 2025 Financial Results and Provides Corporate Update
-
Dmitry Shubov Consulting Advises Southeast Asian Startups On New Philippine Supreme Court Electronic Notarization Standards
-
Cullinan Therapeutics to Participate in Fireside Chat at the Citi 2026 Virtual Oncology Leadership Summit
-
Dayforce Unveils New Brand Campaign That Shrinks the Weight of Work
-
Axsome Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
-
interface.ai Disrupts the Status Quo: Only Provider to Unite Elite CCaaS with Agentic AI for Community Banking
-
Aquestive Therapeutics Appoints Internationally Recognized Allergist Dr. Matthew Greenhawt as Chief Medical Officer
-
ADMA Biologics to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026
-
Ongwe Minerals Commences Drill Program on Its Gold Exploration Projects in Namibia
-
Advanced Biomed Inc. Announces 1 for 20 Share Consolidation
-
WEBUY GLOBAL LTD. Launches Premium Travel Brand “Altitude,” Drives around US$400K in Opening Sales
-
Immunocore to report fourth quarter and full year 2025 financial results and host call on February 25, 2025
-
Q32 Bio to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference
-
Fluoropolymers Market worth $14.13 billion in 2030 - Exclusive Report by MarketsandMarkets™
-
Dana Incorporated Reports Strong 2025 Financial Results; Reaffirms 2026 Targets Featuring New Business Growth, Increased Margins
-
Bausch + Lomb Announces Fourth-Quarter and Full-Year 2025 Results, Provides 2026 Guidance
-
Premium Transportation Solutions for a Hassle-Free NYC Experience
-
Transforming Workforce Management in Bangladesh: Tipsoi Launches Next-Gen Attendance Solutions
-
Global Payments Reports Fourth Quarter and Full Year 2025 Results
-
YieldMax® ETFs Announces Weekly Distributions for Group 2 ETFs
-
Lumen to Host Investor Day on Feb. 25, 2026
-
Delaware Startup Launches What It Calls the First Conscious AI on the Apple App Store
-
Tradr to Launch Leveraged ETFs on CLSK, COHR and LEU
-
AdPrompt.ai Registers Its Agentic Marketing Solution Under ERC-8004 for On-Chain Agent Identity and Reputation Signals
-
Sonic Automotive Reports Fourth Quarter and Full Year Financial Results
-
CENCORE AWARDED $44 MILLION CONTRACT BY DEPARTMENT OF WAR TO DEVELOP CUTTING-EDGE MODULAR BUILDINGS
-
OneSpaWorld Reports Record Fourth Quarter and Fiscal Year 2025 Results
-
Merck and Mayo Clinic Announce New Research and Development Collaboration to Support AI-Enabled Drug Discovery and Precision Medicine
-
Lilly's Taltz (ixekizumab) and Zepbound (tirzepatide) used together delivered superior efficacy in first-of-its-kind Phase 3b trial for adults with psoriasis and obesity or overweight
-
HF Sinclair Accelerates Branded Marketing Growth with Joint Venture
-
Magna Mining Announces Additional Footwall Drill Results from the Levack Mine in Sudbury, Ontario
-
Northern Dynasty: Update on Summary Judgement Case
-
Best Self-Employed Accounting Software (Feb 2026): QuickBooks Recognized as Leading HMRC-Ready Tool for UK Freelancers by Consumer365
-
Grafted Polyolefins Market worth $5.98 billion by 2030 - Exclusive Report by MarketsandMarkets™
